Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nearly one in five children in Switzerland at risk of poverty
‘Switzerland is a partial member of the EU,' says historian Read more: ‘Switzerland is a partial member of the EU,' says historian Rising inequality, diesel deal and another execution Read more: Rising inequality, diesel deal and…
Health Care Down, But not by Much, Amid Defensive Bias -- Health Care Roundup
Health-care companies fell, but not by as much as the broad market, as traders rotated out of the technology sector into defensive areas. Shares of major health insurers such as UnitedHealth gave back some of their gains for the week but remained…
Switzerland advances bid to host 2038 Winter Olympics
‘Switzerland is a partial member of the EU,' says historian Read more: ‘Switzerland is a partial member of the EU,' says historian Rising inequality, diesel deal and another execution Read more: Rising inequality, diesel deal and…
Trump bought millions in drug stocks before Medicare change-Democrat report
President Donald Trump's investment portfolio bought as much as $2.55 million worth of stock in pharmaceutical companies that later benefited from changes to Medicare drug price negotiations, including purchases made just days before Trump signed…
Five workers killed, many injured in blast at chemical unit in Gujarat's Bharuch
As many as five workers were killed and five others injured after an explosion ripped through a chemical manufacturing unit in Gujarat's Bharuch district, officials said on Saturday (October 17, 2026). The blast occurred around 10 p.m. on Friday…
Bonfiglioli IPO: Exposure to manufacturing and infrastructure led growth
Bonfiglioli Transmissions – a leading domestic manufacturer of gearboxes and drives – is launching an IPO that closes on Oct 19. The company is a 100 per cent subsidiary of Bonfiglioli S.p.A., a 70-year-old Italian family-owned…
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Not all high-yield dividend stocks are created equal. Some are genuine income compounders, while others are traps. And the current environment, with interest rates on the rise, makes it more difficult to differentiate the good from the bad. AbbVie…
FSSAI issues notices to Nestle, HUL for misleading claims
The Food Safety and Standards Authority of India on Saturday said that it has issued notices to Nestlé India and Hindustan Unilever regarding misleading claims and non-compliances with regards to certain products. It has also suspended…
AbbVie's Dividend Keeps Climbing. Is It Still a Buy for Income Investors?
Dow Jones51,999.60−0.44% Nasdaq 10029,213.40−2.32% Russell 20002,724.81−1.63% Dow Jones51,999.60−0.44% Nasdaq 10029,213.40−2.32% Russell 20002,724.81−1.63% Dow Jones51,999.60−0.44% Nasdaq…
AbbVie Inc. $ABBV Shares Acquired by Cyndeo Wealth Partners LLC
Cyndeo Wealth Partners LLC lifted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 2.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,048 shares of the…
AbbVie Inc. $ABBV Stock Sold by Cardinal Capital Management Inc.
Cardinal Capital Management Inc. lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional…
AptarGroup (NYSE:ATR) Share Price Breaks Above Two Hundred Day Moving Average - Here's Why
AptarGroup, Inc. (NYSE:ATR - Get Free Report) shares passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $125.17 and traded as high as $125.99. AptarGroup shares last traded at $124.47, with a…
Mutual Funds returns
EQUITY - LARGE & MID CAP FUNDS Bandhan Large & Mid Cap Fund HYBRID - BALANCED ADVANTAGE FUNDS Baroda BNP Paribas Balanced Advantage HYBRID - AGGRESSIVE HYBRID FUNDS BOI AXA Mid & Small Cap Eq&Debt EQUITY - THEMATIC - INFRASTRUCTURE FUNDS BOI AXA…
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Moved Up to 'Buy' by Wall Street Zen
Vertex Pharmaceuticals (NASDAQ:VRTX - Get Free Report) was upgraded by analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a report released on Saturday, Wall Street Zen reports. Vertex's Crinetics Deal Balances Growth with…
Wall Street Zen Upgrades argenex (NASDAQ:ARGX) to Buy
argenex (NASDAQ:ARGX - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a note issued to investors on Saturday, Wall Street Zen reports. 2 Ways to Play the Big Pharma Patent Cliff…
Receive a Daily briefing on Pharma Industry News
Get Started